Veterinary Medicines

Rabigen Mono, süstesuspensioon koertele ja kassidele

Authorised
  • Rabies virus, strain VP12, Inactivated
Download as PDF

Product identification

Medicine name:
Rabigen Mono, süstesuspensioon koertele ja kassidele
Active substance:
  • Rabies virus, strain VP12, Inactivated
Target species:
  • Dog
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain VP12, Inactivated
    1.00
    international unit(s)
    /
    1.00
    dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Available in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1364
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."